Previous expression profiling studies of ovarian tumors have examined the overall survival (“Ovarian Cancer Prognostic Profile” or OCPP) [6] and the chemotherapeutic response (“Chemotherapeutic Response Profile” or CRP) [10] of ovarian cancer patients. This evidence concerns the gene CRP and ovarian carcinoma.